1-(3-Methoxypyridin-2-yl)piperazine

Catalog No. :
ACSEUW268
CAS No. :
80827-67-4
Molecular Formula :
C10H15N3O
Molecular Weight :
193.25

IUPAC Name:1-(3-methoxypyridin-2-yl)piperazine

1-(3-Methoxypyridin-2-yl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg96%$205.00Login to see priceInquiryInquiry
250mg96%$322.00Login to see priceInquiryInquiry
1g96%$780.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Methoxypyridin-2-yl)piperazine
IUPAC Name1-(3-methoxypyridin-2-yl)piperazine
MDL No.MFCD04115059
Molecular FormulaC10H15N3O
Molecular Weight193.25
SMILESCOC1=CC=CN=C1N2CCNCC2
InChI KeyKLNMSBVPRVBART-UHFFFAOYSA-N
Synonym1-(3-methoxypyridin-2-yl)piperazine | 80827-67-4 | 1-(3-METHOXY-PYRIDIN-2-YL)-PIPERAZINE | Piperazine, 1-(3-methoxy-2-pyridinyl)- | Piperazine,1-(3-methoxy-2-pyridinyl)- | SCHEMBL1026306 | CHEMBL4587839 | DTXSID90509951 | KLNMSBVPRVBART-UHFFFAOYSA-N | 1-(3-methoxy-2pyridin
CAS No.80827-67-4
PubChem CID12790495

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302+H312+H332-H315-H319-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACSEUW268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACNWJC786 route compound structure diagram
    ACNWJC78624100-18-3 In Stock
  4. Then
  5. ACSEUW268 route product structure diagram
    ACSEUW26880827-67-4
Inquiry

2. ACSEUW268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACETQO835 route compound structure diagram
    ACETQO83552605-96-6 In Stock
  4. Then
  5. ACSEUW268 route product structure diagram
    ACSEUW26880827-67-4
Inquiry

Comments (0)